News

May 18, 2010—Andrew Lees, Scientific Director of Fina BioSolutions, has been appointed Associate Professor of Medicine, part time, to the faculty of the Department of Medicine at the University of Maryland School of Medicine, Baltimore, Maryland.

September 18, 2009—Fina BioSolutions announces an upcoming webinar: Title: Enhancing Process Economics and Improving Product Purity Date: Thursday, September 24, 2009 Time: 2:00 PM - 3:00 PM EDT Space is limited - reserve your Webinar seat now. After registering you will receive a confirmation email containing information about joining the Webinar. Event Information A presentation and discussion led by: Andrew continue→

July 1, 2009—Andrew Lees, Scientific Director of Fina BioSolutions, joins the scientific advisory board of BioExcellence India. He will be assisting with bioprocessing training and curriculum development. Bioexcellence India, Foundation for Biotechnology Education Research and Training is a not for profit organization incepted for promotion of biotechnology and allied sciences. The mission continue→

May 2, 2009—Fina BioSolutions partners with U.S. VirGene to provide cloning and molecular biology services. US VirGene Inc. is a bio-tech company devoted to the development of novel application for bio-products in the food and pharmaceutical industry. More specifically, the company seeks to discover new uses for bio-enzymes in the area continue→

May 1, 2009—Stephanie Channing joins Fina Bio to assist with the development of conjugate vaccines.

March 1, 2008—Jesse Edwards, Ph.D., joins Fina Bio as Director of Protein Purification. Dr. Edwards, formerly… of Kemp Biotech,

December 1, 2007—Fina BioSolutions acquires an Akta Purifier and an Akta FPLC. The acquisition of these chromatography systems will allow Fina to perform automated process development. These systems augment the four Waters HPLC systems already in place for protein purification and analysis.

July 1, 2007—Fina BioSolutions can now provide capillary SDS electrophoresis through an agreement with BioTaq of Gaithersburg, MD (http://www.biotaq.com/). Access to an Agilent BioAnalyzer 2100 will permit computerized, lab-on-a-chip electrophoresis for process development and protein characterization.

June 1, 2007—Antibody and Immunoassay Consultants, LLC of Rockville, MD (http://aicbiotech.com/) will provide immunology, and immunoassay services for Fina BioSolutions. AIC is located adjacent to Fina BioSolutions.

January 1, 2007—Fina will provide novel conjugation chemistry for meningitis and pneumonia conjugate vaccines. Serum Institute of India Ltd. has established itself as the world's largest producer of Measles and DTP group of vaccines. It is estimated that two out of every three children immunized in the world is vaccinated by a vaccine continue→